Monitor for additional selling by insiders; the single sale is routine at this size but notable given it's the CEO. The large grant suggests continued long-term alignment.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $18.89entry
- T+1 · 9mo ago +1.11%α +0.38% · $19.10
- T+5 · 9mo ago +22.50%α +21.88% · $23.14
- T+20 · 8mo ago +1.32%α +5.27% · $19.14
- T+60 · 6mo ago +13.55%α +5.30% · $21.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
10x Genomics CEO Saxonov sold $324K in open-market shares while receiving a large non-cash stock award; CFO and another executive also received non-cash awards. The only material cash transaction was the CEO's sale, representing a modest portion of his holdings.
Key Financial Metrics
Key Facts
- CEO Saxonov sold 14,292 shares for $323,985 in open-market transactions
- CEO also received a grant of 157,895 shares (non-cash, $0 value)
- CFO Taich received a grant of 106,579 shares (non-cash)
- All other transactions were non-cash (grants or gifts) with no economic value
- Total open-market selling: $324K, representing 0.01% of $2.9B market cap
Financial Impact
$324K in open-market selling by CEO, offset by non-cash grants
Risk Factors
- Perception of insider selling ahead of potential headwinds
- Dilution from share grants, though standard for tech firms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-TXG-1772658947598 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers